Wall Street Analysts Predict a 52.5% Upside in Jade Biosciences, Inc. (JBIO): Here's What You Should Know

Shares of Jade Biosciences, Inc. (JBIO) have gained 25.9% over the past four weeks to close the last trading session at $12.59, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $19.2 indicates a potential upside of 52.5%.The average comprises five short-term price targets ranging from a low of $14.00 to a high of $28.00, with a standard deviation of $5.36. While the lowest estima ...